Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
177Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial
Michael J. Morris, Daniel Castellano, Ken Herrmann, Johann Sebastian De Bono, Neal D. Shore, Kim N. Chi and 17 more
- Rank
- 32 of 1,531
- Percentile
- top 2.1%
- Where
- The Lancet, 2024
- Citations
- 357
From the 2024 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.